- Home
- WKHS vs ELEV Comparison
WKHS vs ELEV Comparison
Compare WKHS & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKHS
- ELEV
- Stock Information
- Founded
- WKHS 2007
- ELEV 2019
- Country
- WKHS United States
- ELEV United States
- Employees
- WKHS N/A
- ELEV N/A
- Industry
- WKHS Auto Manufacturing
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- WKHS Consumer Discretionary
- ELEV Health Care
- Exchange
- WKHS Nasdaq
- ELEV Nasdaq
- Market Cap
- WKHS 44.3M
- ELEV 37.6M
- IPO Year
- WKHS N/A
- ELEV 2021
- Fundamental
- Price
- WKHS $0.81
- ELEV $0.63
- Analyst Decision
- WKHS Sell
- ELEV Strong Buy
- Analyst Count
- WKHS 3
- ELEV 5
- Target Price
- WKHS $5.75
- ELEV $7.20
- AVG Volume (30 Days)
- WKHS 2.7M
- ELEV 720.2K
- Earning Date
- WKHS 11-19-2024
- ELEV 11-06-2024
- Dividend Yield
- WKHS N/A
- ELEV N/A
- EPS Growth
- WKHS N/A
- ELEV N/A
- EPS
- WKHS N/A
- ELEV N/A
- Revenue
- WKHS $9,097,780.00
- ELEV N/A
- Revenue This Year
- WKHS N/A
- ELEV N/A
- Revenue Next Year
- WKHS $247.90
- ELEV N/A
- P/E Ratio
- WKHS N/A
- ELEV N/A
- Revenue Growth
- WKHS N/A
- ELEV N/A
- 52 Week Low
- WKHS $0.57
- ELEV $0.44
- 52 Week High
- WKHS $8.18
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- WKHS 36.58
- ELEV 49.52
- Support Level
- WKHS $0.99
- ELEV $0.61
- Resistance Level
- WKHS $1.26
- ELEV $0.70
- Average True Range (ATR)
- WKHS 0.09
- ELEV 0.08
- MACD
- WKHS -0.04
- ELEV 0.00
- Stochastic Oscillator
- WKHS 0.00
- ELEV 25.10
About WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.